Selected article for: "control clinical prevention and epidemic control prevention"
Author: Li, Xingchao; Sun, Li; Li, Tao
Title: Updates in neonatal coronavirus disease 2019: What can we learn from detailed case reports?
  • Cord-id: hhuydjo4
  • Document date: 2021_3_11
    • ID: hhuydjo4
    Snippet: Although the COVID-19 epidemic has lasted for months, it has not yet been successfully controlled, and little is known about neonatal COVID-19. Therefore, literature search was conducted for references in PubMed, Science Direct, ProQuest, Web of Science and China National Knowledge Infrastructure for detailed case reports on neonatal COVID-19 published as of July 15, 2020, to facilitate the clinical treatment, epidemic prevention and control of neonatal COVID-19. Forty nonoverlapping case report
    Document: Although the COVID-19 epidemic has lasted for months, it has not yet been successfully controlled, and little is known about neonatal COVID-19. Therefore, literature search was conducted for references in PubMed, Science Direct, ProQuest, Web of Science and China National Knowledge Infrastructure for detailed case reports on neonatal COVID-19 published as of July 15, 2020, to facilitate the clinical treatment, epidemic prevention and control of neonatal COVID-19. Forty nonoverlapping case reports focusing mainly on the demographic characteristics, transmission modes, clinical features, treatments and prognosis of neonatal COVID-19, including 3 in Chinese and 37 in English, were available.

    Search related documents:
    Co phrase search for related documents
    • address need and long distance: 1
    • address need and long hospitalization: 1
    • address need and long term short: 1, 2, 3, 4, 5, 6, 7
    • address need and long term short term: 1, 2, 3
    • address need and lopinavir ritonavir: 1
    • liver enzyme and lopinavir ritonavir: 1, 2, 3, 4
    • liver enzyme and low mortality: 1
    • long distance and lopinavir ritonavir: 1, 2
    • long hospitalization and low incidence: 1
    • long hospitalization and low mortality: 1
    • long term short and lopinavir ritonavir: 1
    • long term short and low incidence: 1, 2
    • long term short and low mortality: 1, 2, 3, 4, 5, 6, 7, 8
    • long term short outcome and low mortality: 1, 2
    • lopinavir ritonavir and low incidence: 1
    • lopinavir ritonavir and low mortality: 1, 2, 3, 4, 5, 6, 7, 8